Applications of Nanotechnology in Drug Discovery and Delivery 2022
DOI: 10.1016/b978-0-12-824408-1.00005-3
|View full text |Cite
|
Sign up to set email alerts
|

Nanotechnological application of peptide- and protein-based therapeutics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

3
0

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 68 publications
1
3
0
Order By: Relevance
“…Therefore, egg proteins are very effective against atopic disease, edematous malnutrition, inflammation, and weight loss in infants (Guha et al, 2019;Mine, 2015;Strixner & Kulozik, 2011). cially IgA, has the potential to provide the first line of defense against pathogenic microbes, including viruses and bacteria (Awuchi, Akram, et al, 2022;Awuchi, Chukwu, et al, 2022;Woof & Kerr, 2006). The findings of current research work are similar to the study in which celiac disease patients were treated with egg protein powders for a period of 6 months.…”
Section: Serum Proteinssupporting
confidence: 62%
See 1 more Smart Citation
“…Therefore, egg proteins are very effective against atopic disease, edematous malnutrition, inflammation, and weight loss in infants (Guha et al, 2019;Mine, 2015;Strixner & Kulozik, 2011). cially IgA, has the potential to provide the first line of defense against pathogenic microbes, including viruses and bacteria (Awuchi, Akram, et al, 2022;Awuchi, Chukwu, et al, 2022;Woof & Kerr, 2006). The findings of current research work are similar to the study in which celiac disease patients were treated with egg protein powders for a period of 6 months.…”
Section: Serum Proteinssupporting
confidence: 62%
“…Moreover, the immunoglobulin E (IgE) level remained unchanged in all pups fed high levels of egg protein and plant protein diets. The type of immunoglobulin, especially IgA, has the potential to provide the first line of defense against pathogenic microbes, including viruses and bacteria (Awuchi, Akram, et al, 2022 ; Awuchi, Chukwu, et al, 2022 ; Woof & Kerr, 2006 ). The findings of current research work are similar to the study in which celiac disease patients were treated with egg protein powders for a period of 6 months.…”
Section: Resultsmentioning
confidence: 99%
“…The bioavailability of bioactive compounds during human digestion can be increased by encapsulating bioactive substances. The encapsulation increases the bioactive ingredients' water solubility, safeguards them from adverse circumstances in a specific area of the digestive tract (such as the stomach), and emits them in a targeted area (such as the intestine) for improved human absorption [70,71]. For instance, amylose inclusion structures enhanced the in vivo efficacy of genistein (a type of isoflavones) in a rat model [70].…”
Section: Encapsulation Of Probioticmentioning
confidence: 99%
“…Chitosan, the second‐most prevalent polysaccharide in the world, which is produced by the alkali deacetylation process of chitin, is a natural, nontoxic, biodegradable, and biocompatible polymer, with antimicrobial properties (Awuchi, Akram, et al, 2022 ; Awuchi, Morya, et al, 2022 ; Egbuna et al, 2021 ). Also, barrier properties and superior film‐forming and coating abilities have been proven for this biopolymer (Vlad‐Bubulac et al, 2022 ).…”
Section: Introductionmentioning
confidence: 99%